RECITALSLicense Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Virginia
AGREEMENTAgreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.42 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. LICENSE AGREEMENT This LICENSE...License Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
ADDENDUMIsta Pharmaceuticals Inc • April 30th, 2003 • In vitro & in vivo diagnostic substances • Virginia
EXHIBIT 10.45 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDMENT TO BROMFENAC LICENSE...Bromfenac License Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
AcSentient, Inc. 110 Doric Court Morrisville, NC 27560 April 26, 2002 Eastern Virginia Medical School 825 Fairfax Avenue Norfolk, VA 23507 Re: Sale of Certain Assets of AcSentient, Inc. to ISTA Pharmaceuticals, Inc. Dear Dr. Bell: Pursuant to an Asset...Ista Pharmaceuticals Inc • April 30th, 2003 • In vitro & in vivo diagnostic substances
Pursuant to an Asset Purchase Agreement, AcSentient, Inc. ("AcSENTIENT") is selling to ISTA Pharmaceuticals, Inc. ("ISTA") certain assets including the License Agreement by and between Eastern Virginia Medical School, dated January 29, 2002 (the "LICENSE").
EXHIBIT 10.46 CONFIDENTIAL PORTIONS HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION. AMENDMENT TO TIMOLOL AGREEMENT This...Timolol Agreement • April 30th, 2003 • Ista Pharmaceuticals Inc • In vitro & in vivo diagnostic substances
